litlas
ログインアカウント作成

Terra L. Lasho

2004–2025 年に発表

126
論文数
19,410
被引用数
81
h 指数
121
i10 指数

被引用数

Terra L. Lasho の年別被引用数2005 年: 被引用 24 件2006 年: 被引用 90 件2007 年: 被引用 148 件2008 年: 被引用 142 件2009 年: 被引用 146 件2010 年: 被引用 159 件2011 年: 被引用 165 件2012 年: 被引用 177 件2013 年: 被引用 198 件2014 年: 被引用 227 件2015 年: 被引用 214 件2016 年: 被引用 202 件2017 年: 被引用 169 件2018 年: 被引用 170 件2019 年: 被引用 507 件2020 年: 被引用 667 件2021 年: 被引用 607 件2022 年: 被引用 579 件2023 年: 被引用 332 件2024 年: 被引用 573 件2025 年: 被引用 195 件2026 年: 被引用 6 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,445 件、この内訳の 29.1%イタリア: 引用元論文 477 件、この内訳の 9.6%ドイツ: 引用元論文 389 件、この内訳の 7.8%フランス: 引用元論文 351 件、この内訳の 7.1%イギリス: 引用元論文 333 件、この内訳の 6.7%スペイン: 引用元論文 196 件、この内訳の 3.9%中国: 引用元論文 179 件、この内訳の 3.6%カナダ: 引用元論文 144 件、この内訳の 2.9%オーストリア: 引用元論文 134 件、この内訳の 2.7%スイス: 引用元論文 111 件、この内訳の 2.2%オランダ: 引用元論文 109 件、この内訳の 2.2%オーストラリア: 引用元論文 102 件、この内訳の 2.1%
0%29.1%その他 20.1%

機関

分野

  • Medicine81.7%
  • Biochemistry, Genetics and Molecular Biology9.5%
  • Immunology and Microbiology7.9%
  • Pharmacology, Toxicology and Pharmaceutics0.2%
  • Computer Science0.2%
  • Neuroscience0.1%
  • その他0.4%

トピック

  • Myeloproliferative Neoplasms: Diagnosis and Treatment19.3%
  • Acute Myeloid Leukemia Research15%
  • Eosinophilic Disorders and Syndromes7%
  • Kruppel-like factors research6.8%
  • Chronic Myeloid Leukemia Treatments6.2%
  • Mast cells and histamine2.4%
  • その他43.3%

共著者

全論文

検索で開く
  1. MIPSS70: Mutation-Enhanced International Prognostic Score System for Transplantation-Age Patients With Primary Myelofibrosis

    著者: Paola Guglielmelli, Terra L. Lasho, Giada Rotunno, Mythri Mudireddy, Carmela Mannarelli, Maura Nicolosi, Annalisa Pacilli, Animesh Pardanani, Elisa Rumi, Vittorio Rosti, Curtis A. Hanson, Francesco Mannelli, Rhett P. Ketterling, Naseema Gangat, Alessandro Rambaldi, Francesco Passamonti, Giovanni Barosi, Tiziano Barbui, Mario Cazzola, Alessandro M. Vannucchi, Ayalew Tefferi - Journal of Clinical Oncology 2017 被引用: 532

  2. Spectrum of clonal hematopoiesis in VEXAS syndrome

    著者: Fernanda Gutierrez‐Rodrigues, Yael Kusne, Jenna Fernandez, Terra L. Lasho, Ruba Shalhoub, Xiaoyang Ma, Hugh Alessi, Christy M. Finke, Matthew J. Koster, Abhishek A. Mangaonkar, Kenneth J. Warrington, Kebede H. Begna, Zhuoer Xie, Amanda K. Ombrello, David S. Viswanatha, Marcela A. Ferrada, Lorena Wilson, Ronald S. Go, Taxiarchis Kourelis, Kaaren K. Reichard, Horatiu Olteanu, Ivana Darden, Dalton Hironaka, Lemlem Alemu, Sachiko Kajigaya, Rodrigo T. Calado, Emma M. Groarke, Sofia Rosenzweig, Daniel L. Kastner, Katherine R. Calvo, Colin O. Wu, Peter C. Grayson, Neal S. Young, David B. Beck, Bhavisha A. Patel, Mrinal M. Patnaik - Blood 2023 被引用: 103

  3. Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis

    著者: Ayalew Tefferi, Paola Guglielmelli, Dirk R. Larson, Christy M. Finke, Emnet A Wassie, Lisa Pieri, Naseema Gangat, Rajmonda Fjerza, Alem A. Belachew, Terra L. Lasho, Rhett P. Ketterling, Curtis A. Hanson, Alessandro Rambaldi, Guido Finazzi, Jüergen Thiele, Tiziano Barbui, Animesh Pardanani, Alessandro M. Vannucchi - Blood 2014 被引用: 727

  4. Circulating Interleukin (IL)-8, IL-2R, IL-12, and IL-15 Levels Are Independently Prognostic in Primary Myelofibrosis: A Comprehensive Cytokine Profiling Study

    著者: Ayalew Tefferi, Rakhee Vaidya, Domenica Caramazza, Christy M. Finke, Terra L. Lasho, Animesh Pardanani - Journal of Clinical Oncology 2011 被引用: 586

  5. MIPSS70+ Version 2.0: Mutation and Karyotype-Enhanced International Prognostic Scoring System for Primary Myelofibrosis

    著者: Ayalew Tefferi, Paola Guglielmelli, Terra L. Lasho, Naseema Gangat, Rhett P. Ketterling, Animesh Pardanani, Alessandro M. Vannucchi - Journal of Clinical Oncology 2018 被引用: 383

  6. Mutation‐enhanced international prognostic systems for essential thrombocythaemia and polycythaemia vera

    著者: Ayalew Tefferi, Paola Guglielmelli, Terra L. Lasho, Giacomo Coltro, Christy M. Finke, Giuseppe Gaetano Loscocco, Benedetta Sordi, Natasha Szuber, Giada Rotunno, Annalisa Pacilli, Curtis A. Hanson, Rhett P. Ketterling, Animesh Pardanani, Naseema Gangat, Alessandro M. Vannucchi - British Journal of Haematology 2020 被引用: 221

  7. GIPSS: genetically inspired prognostic scoring system for primary myelofibrosis

    著者: Ayalew Tefferi, Paola Guglielmelli, Maura Nicolosi, Francesco Mannelli, Mythri Mudireddy, Niccolò Bartalucci, Christy M. Finke, Terra L. Lasho, Curtis A. Hanson, Rhett P. Ketterling, Kebede H. Begna, Naseema Gangat, Animesh Pardanani, Alessandro M. Vannucchi - Leukemia 2018 被引用: 294

  8. One Thousand Patients With Primary Myelofibrosis: The Mayo Clinic Experience

    著者: Ayalew Tefferi, Terra L. Lasho, Thitina Jimma, Christy M. Finke, Naseema Gangat, Rakhee Vaidya, Kebede H. Begna, Aref Al‐Kali, Rhett P. Ketterling, Curtis A. Hanson, Animesh Pardanani - Mayo Clinic Proceedings 2012 被引用: 249

  9. Targeted deep sequencing in polycythemia vera and essential thrombocythemia

    著者: Ayalew Tefferi, Terra L. Lasho, Paola Guglielmelli, Christy M. Finke, Giada Rotunno, Yoseph Elala, Annalisa Pacilli, Curtis A. Hanson, Alessandro Pancrazzi, Rhett P. Ketterling, Carmela Mannarelli, Daniela Barraco, Tiziana Fanelli, Animesh Pardanani, Naseema Gangat, Alessandro M. Vannucchi - Blood Advances 2016 被引用: 301

  10. Myeloproliferative neoplasms in the young: Mayo Clinic experience with 361 patients age 40 years or younger

    著者: Natasha Szuber, Rangit Vallapureddy, Domenico Penna, Terra L. Lasho, Christy M. Finke, Curtis A. Hanson, Rhett P. Ketterling, Animesh Pardanani, Naseema Gangat, Ayalew Tefferi - American Journal of Hematology 2018 被引用: 90

  11. A Pilot Study of the Telomerase Inhibitor Imetelstat for Myelofibrosis

    著者: Ayalew Tefferi, Terra L. Lasho, Kebede H. Begna, Mrinal M. Patnaik, Darci Zblewski, Christy M. Finke, Rebecca R. Laborde, Emnet A Wassie, Lauren Schimek, Curtis A. Hanson, Naseema Gangat, Xiaolin Wang, Animesh Pardanani - New England Journal of Medicine 2015 被引用: 322

  12. VEXAS syndrome: Clinical, hematologic features and a practical approach to diagnosis and management

    著者: Matthew J. Koster, Terra L. Lasho, Horatiu Olteanu, Kaaren K. Reichard, Abhishek A. Mangaonkar, Kenneth J. Warrington, Mrinal M. Patnaik - American Journal of Hematology 2023 被引用: 68

  13. Reduced intensity conditioning allogeneic hematopoietic stem cell transplantation in VEXAS syndrome: Data from a prospective series of patients

    著者: Abhishek A. Mangaonkar, Kimberly J. Langer, Terra L. Lasho, Christy M. Finke, Mark R. Litzow, William J. Hogan, Mithun Vinod Shah, Ronald S. Go, Gabriel Bartoo, Jade L. Kutzke, Kristen McCullough, Matthew J. Koster, Matthew J. Samec, Kenneth J. Warrington, Kaaren K. Reichard, Horatiu Olteanu, Mary Riwes, Mrinal M. Patnaik, Hassan B. Alkhateeb - American Journal of Hematology 2022 被引用: 48

  14. MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients

    著者: Animesh Pardanani, Ross L. Levine, Terra L. Lasho, Yana Pikman, Ruben A. Mesa, Martha Wadleigh, David P. Steensma, Michelle A. Elliott, Alexandra P. Wolanskyj, William J. Hogan, Rebecca F. McClure, Mark R. Litzow, D. Gary Gilliland, Ayalew Tefferi - Blood 2006 被引用: 1,039

  15. Sex and degree of severity influence the prognostic impact of anemia in primary myelofibrosis: analysis based on 1109 consecutive patients

    著者: Maura Nicolosi, Mythri Mudireddy, Terra L. Lasho, Curtis A. Hanson, Rhett P. Ketterling, Naseema Gangat, Animesh Pardanani, Ayalew Tefferi - Leukemia 2018 被引用: 81

  16. 3023 Mayo Clinic Patients With Myeloproliferative Neoplasms: Risk-Stratified Comparison of Survival and Outcomes Data Among Disease Subgroups

    著者: Natasha Szuber, Mythri Mudireddy, Maura Nicolosi, Domenico Penna, Rangit Vallapureddy, Terra L. Lasho, Christy M. Finke, Kebede H. Begna, Michelle A. Elliott, C. Christopher Hook, Alexandra P. Wolanskyj, Mrinal M. Patnaik, Curtis A. Hanson, Rhett P. Ketterling, Shireen Sirhan, Animesh Pardanani, Naseema Gangat, Lambert Busque, Ayalew Tefferi - Mayo Clinic Proceedings 2019 被引用: 163

  17. Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors

    著者: Ken‐Hong Lim, Ayalew Tefferi, Terra L. Lasho, Christy M. Finke, Mrinal M. Patnaik, Joseph H. Butterfield, Rebecca F. McClure, Chin‐Yang Li, Animesh Pardanani - Blood 2009 被引用: 574

  18. The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patients

    著者: Paola Guglielmelli, Terra L. Lasho, Giada Rotunno, J Score, C Mannarelli, Alessandro Pancrazzi, Flavia Biamonte, Animesh Pardanani, Katerina Zoi, A. Reiter, Andrew Duncombe, Tiziana Fanelli, Daniela Pietra, Elisa Rumi, Christy M. Finke, Naseema Gangat, Rhett P. Ketterling, Ryan A. Knudson, Curtis A. Hanson, Alberto Bosi, Arturo Pereira, Rossella Manfredini, Francisco Cervantes, G. Barosi, M. Cazzola, Nicholas C.P. Cross, A. M. Vannucchi, Ayalew Tefferi - Leukemia 2014 被引用: 308

  19. Validation of the revised international prognostic score of thrombosis for essential thrombocythemia (IPSET‐thrombosis) in 585 Mayo clinic patients

    著者: Mahnur Haider, Naseema Gangat, Terra L. Lasho, Ahmed Kamel Abou Hussein, Yoseph Elala, Curtis A. Hanson, Ayalew Tefferi - American Journal of Hematology 2016 被引用: 145

  20. RAS mutations drive proliferative chronic myelomonocytic leukemia via a KMT2A-PLK1 axis

    著者: Ryan M. Carr, Denis Vorobyev, Terra L. Lasho, David L. Marks, Ezequiel J. Tolosa, Alexis Vedder, Luciana L. Almada, Andrey Yurcheko, Ismaël Padioleau, Bonnie Alver, Giacomo Coltro, Moritz Binder, Stephanie L. Safgren, Isaac P. Horn, Xiaona You, Éric Solary, Maria E. Balasis, Kurt Berger, James W. Hiebert, Thomas E. Witzig, Ajinkya Buradkar, Temeida Graf, Peter Valent, Abhishek A. Mangaonkar, Keith D. Robertson, Matthew T. Howard, Scott H. Kaufmann, Christopher L. Pin, Martín E. Fernández-Zapico, Klaus Geißler, Nathalie Droin, Eric Padron, Jing Zhang, Sergey I. Nikolaev, Mrinal M. Patnaik - Nature Communications 2021 被引用: 100

  21. Spliceosome mutations involving SRSF2, SF3B1, and U2AF35 in chronic myelomonocytic leukemia: Prevalence, clinical correlates, and prognostic relevance

    著者: Mrinal M. Patnaik, Terra L. Lasho, Christy M. Finke, Curtis A. Hanson, Janice M. Hodnefield, Ryan A. Knudson, Rhett P. Ketterling, Animesh Pardanani, Ayalew Tefferi - American Journal of Hematology 2012 被引用: 151

  22. Patients with telomere biology disorders show context specific somatic mosaic states with high frequency of U2AF1 variants

    著者: Alejandro Ferrer, Terra L. Lasho, Jenna Fernandez, Nickolas Steinauer, Rachel A Simon, Christy M. Finke, Eva M. Carmona, Mark E. Wylam, Laura J. Ongie, Brittany Burnap, Cecilia Y. Arana Yi, Lisa Z. Sproat, James M. Foran, Talha Badar, Abhishek A. Mangaonkar, Mrinal M. Patnaik - American Journal of Hematology 2023 被引用: 22

  23. ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patients

    著者: Mrinal M. Patnaik, Raphaël Itzykson, Terra L. Lasho, Olivier Kosmider, Christy M. Finke, Curtis A. Hanson, Ryan A. Knudson, Rhett P. Ketterling, Ayalew Tefferi, Éric Solary - Leukemia 2014 被引用: 282

  24. CYT387, a selective JAK1/JAK2 inhibitor: in vitro assessment of kinase selectivity and preclinical studies using cell lines and primary cells from polycythemia vera patients

    著者: Animesh Pardanani, Terra L. Lasho, Graeme Smith, Christopher J. Burns, Emmanuelle Fantino, Ayalew Tefferi - Leukemia 2009 被引用: 205